Cite
Novel HCV NS5B polymerase inhibitors derived from 4-(1′,1′-dioxo-1′,4′-dihydro-1′λ6-benzo[1′,2′,4′]thiadiazin-3′-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 1: Exploration of 7′-substitution of benzothiadiazine
MLA
Zhou, Yuefen, et al. “Novel HCV NS5B Polymerase Inhibitors Derived from 4-(1′,1′-Dioxo-1′,4′-Dihydro-1′λ6-Benzo[1′,2′,4′]Thiadiazin-3′-Yl)-5-Hydroxy-2H-Pyridazin-3-Ones. Part 1: Exploration of 7′-Substitution of Benzothiadiazine.” Bioorganic & Medicinal Chemistry Letters, vol. 18, no. 4, Feb. 2008, pp. 1413–18. EBSCOhost, https://doi.org/10.1016/j.bmcl.2008.01.007.
APA
Zhou, Y., Webber, S. E., Murphy, D. E., Li, L.-S., Dragovich, P. S., Tran, C. V., Sun, Z., Ruebsam, F., Shah, A. M., Tsan, M., Showalter, R. E., Patel, R., Li, B., Zhao, Q., Han, Q., Hermann, T., Kissinger, C. R., LeBrun, L., Sergeeva, M. V., & Kirkovsky, L. (2008). Novel HCV NS5B polymerase inhibitors derived from 4-(1′,1′-dioxo-1′,4′-dihydro-1′λ6-benzo[1′,2′,4′]thiadiazin-3′-yl)-5-hydroxy-2H-pyridazin-3-ones. Part 1: Exploration of 7′-substitution of benzothiadiazine. Bioorganic & Medicinal Chemistry Letters, 18(4), 1413–1418. https://doi.org/10.1016/j.bmcl.2008.01.007
Chicago
Zhou, Yuefen, Stephen E. Webber, Douglas E. Murphy, Lian-Sheng Li, Peter S. Dragovich, Chinh V. Tran, Zhongxiang Sun, et al. 2008. “Novel HCV NS5B Polymerase Inhibitors Derived from 4-(1′,1′-Dioxo-1′,4′-Dihydro-1′λ6-Benzo[1′,2′,4′]Thiadiazin-3′-Yl)-5-Hydroxy-2H-Pyridazin-3-Ones. Part 1: Exploration of 7′-Substitution of Benzothiadiazine.” Bioorganic & Medicinal Chemistry Letters 18 (4): 1413–18. doi:10.1016/j.bmcl.2008.01.007.